Zanapezil Free Base(Cat No.:M093330)is a potent, selective acetylcholinesterase inhibitor developed for neurodegenerative research, particularly Alzheimer’s disease. It functions by preventing the breakdown of acetylcholine, a neurotransmitter essential for learning and memory, thereby enhancing cholinergic transmission in the brain. Structurally, it is a free base form, offering improved solubility and formulation flexibility for preclinical research. Its pharmacological profile supports investigations into cognitive function, synaptic plasticity, and neuroprotection. Zanapezil is a valuable tool in screening compounds targeting cholinergic pathways and studying mechanisms underlying cognitive impairment and age-related neuronal decline. Intended for in vitro or animal research only.